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PROPER CORONARY VASCULAR DEVELOPMENT AND HEART 
MORPHOGENESIS DEPEND ON INTERACTION OF GATA-4 WITH FOG 
COFACTORS. 
Maya B. Lodish, John D. Crispino, and Stuart H. Orkin. Division of Hematology and 
Oncology, Children’s Hospital, Boston, MA. (Sponsored by Nancy Berliner, Department 
of Medicine, Yale University School of Medicine, New Haven CT). 
The work that forms the basis of this thesis has been published in Genes and Development: 
Crispino, J.D., Lodish M.B., Thurberg, B.L., Litovsky, S.H., Collins, T., Molkntin, J.D., and 
Orkin, S.H. 2001. Proper coronary vascular development and heart morphogenesis depend 
on interaction of GATA-4 with FOG cofactors. Genes and Development. 15:839-844. 
GATA-family transcription factors are critical to the development of diverse tissues. 
In particular, GATA-4 has been implicated in formation of the vertebrate heart. As the 
mouse Gata-4 knock-out is early embryonic lethal because of a defect in ventral 
morphogenesis, the in vivo function of this factor in heart development remains unresolved. 
To search for a requirement for Gata-4 in heart development, we created mice harboring a 
single amino acid replacement in GATA-4 that impairs its physical interaction with its 
presumptive cardiac cofactor FOG-2. Gata-4 ki/ki mice die just after embryonic day 
(E)12.5 exhibiting features in common with Fog-2 -/- embryos as well as additional 
semilunar cardiac valve defects and a double-outlet right ventricle. These findings establish 
an intrinsic requirement for GATA-4 in heart development. We also infer that GATA-4 
function is dependent on interaction with FOG-2 and, very likely, an additional FOG protein 
for distinct aspects of heart formation. 
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Introduction 
The process of mammalian heart development involves the specification of many 
different cell lineages, including coronary vasculature cells, endocardial cells, and 
cardiomyocytes. These cells must assemble into the mature four-chambered heart in a 
specific, complex, and carefully structured manner. This crucial assembly occurs in early 
embryonic development in the mouse, beginning at embryonic day 7.5 and lasting through 
day Ell. Viability of mammals requires the proper synthesis of a beating heart as well as a 
functioning fetal circulatory system. Therefore, it follows that severe defects in cardiac 
development result in embryonic lethality between days 8.5 and 12, while those less severe 
defects result in congenital heart disease! 1). 
The specific stages of cardiac development have been characterized. Murine cardiac 
embryogenesis involves three stages. During the first stage, beginning at day E 7, the 
procardiomyocyte cells differentiate from the cells of the splanchnic mesoderm. During the 
second stage, beginning at day E 8, these procardiomyocytes migrate from the dorsal and 
anterior regions of the embryo to form a linear heart tube. In the third stage of murine 
cardiac embryogenesis, occurring between days 8.5 and 11, septation and looping occur, 
transforming the linear heart tube into the familiar four chambered heart (1). 
Recent advances in the field of molecular biology have identified transcription 
factors that are responsible for the regulation of each stage of cardiac development. Many 
researchers have characterized transcriptional regulatory elements that are expressed in the 
developing mammalian heart. One family of transcription factors that has emerged as 
potential regulators of cardiac development includes the GATA zinc finger family of 
proteins. Current research is directed at better understanding the exact role of the GATA 
transcription factors in the regulation of cardiac development. 
Transcriptional activity of the GATA-factors is modulated through interaction with 
nuclear proteins, including zinc finger proteins of the Kruppel and FOG/U-shaped families, 
general coactivators (p300 and CBP), the myocardial-expressed protein Nkx2.5, and NF- 
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AT3 ( 2, 3, 4, 5).Whereas the specificity and in vivo functional relevance of many of these 
interactions are incompletely defined, the association of GATA-1 with FOG-1 has been 
examined in detail. FOG-1 interacts with GATA-1 in hematopoietic cells and regulates the 
ability of GATA-1 to promote terminal differentiation of erythroid cells and 
megakaryocytes (6). Mutation of specific residues within the conserved N-terminal zinc 
finger of GATA-1, such as V205G, disrupts binding to FOG-1, preserves DNA-binding 
properties of GATA-1, and renders GAT A-1 unable to promote terminal differentiation of 
red blood cells (7). Furthermore, mutation of Val 205 in humans leads to congenital 
dyserythropoietic anemia and thrombocytopenia (8).Taken together, these findings 
demonstrate that direct physical association of GATA-1 and FOG-1 is essential for GATA- 
1 ’s roles in transcription and, critical for the experiments reported herein, identifies a 
specific residue of the N finger that mediates cofactor interaction. 
GATA-4, GATA-5, and GATA-6, nonhematopoietic expressed factors, are 
implicated in development of heart, endoderm, and intestinal epithelia, where they are 
expressed in an overlapping and dynamic fashion (9, 10, 11, 12, 1, 4). GATA-4 has been 
extensively studied in the context of heart development, as it is present in precardiac 
splanchnic mesoderm and binds to and activates promoters and enhancers of numerous 
myocardial-expressed genes (14). In its absence, mouse embryos die by E7.0 -9.5, with 
failure of ventral morphogenesis leading to cardiac bifida (15, 16). The death of the Gata4 
null embryos before formation of a heart tube precludes analysis of the role of this factor in 
later cardiac organogenesis. 
The second member of the FOG protein family, FOG-2, is expressed in cardiac and 
nervous system tissues and interacts with the N fingers of all GATA factors, including those 
expressed within the developing heart (GATA-4, GATA-5, and GATA-6; (17, 18, 19). As 
such, it is a candidate cofactor for these GATA factors in the heart. Mouse embryos lacking 
Fog2 die of heart failure between E12.5 and E15.5 (20, 21). Fog- 2 -/- hearts exhibit a 
constellation of defects, such as overriding aorta, subpulmonic stenosis, and subaortic 
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ventricular septal defect (VSD), seen in the human congenital malformation Tetralogy of 
Fallot. In addition, despite formation of an intact epicardial layer and expression of 
epicardium-specific genes, initiation of coronary vasculature fails to take place. This is 
evidenced by the absence of induction of markers of coronary vessel development, including 
ICAM-2 and Flk-1 in Fog2 -deficient hearts. These defects in coronary vasculature 
formation are secondary to lack of Fog2 expression specifically in myocardium, as 
demonstrated by transgenic rescue (21). 
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Statement of purpose and hypothesis 
The underlying goal of our research is to better understand the molecular regulation 
of mammalian cardiac development. Specifically, we hope to gain insight into the role of the 
interaction between two transcription factors, GATA-4 and FOG-2, in the developing heart. 
The GATA family of transcription factors play important roles in the development of 
multiple organs. In particular, GATA-4 is believed to participate in heart formation. Previous 
studies using knock-out gene targeting for GATA-4 has failed to confirm this, because the 
animals die at points in embryogenesis prior to heart maturation. In contrast, the putative 
GATA-4 cofactor FOG-2 (friend of GATA) is known to be absolutely required for heart 
formation, as mice with targeted deletion of this gene die between E12.5 and E15.5 due to 
severe heart failure (21). To determine whether FOG-2 functions through GATA-4, we 
created a mutant strain of mice that harbor a single point mutation in the GATA-4 gene. 
This mutation alters an amino acid that is required for the interaction between GATA-4 and 
FOG proteins, including FOG-2. Consequently, in our mutant “GATA-4 knock-in” 
animals, GATA-4 and FOG-2 can no longer bind one another. Through examining these 
mice, we attempted to determine the developmental events affected by disrupting the 
interaction between FOG proteins and GATA-4. We hypothesized that mice homozygous 
for this mutation would die in embryogeneis between E 12.5 and El5.5 of heart failure, and 
would exhibit a phenotype similar to that of the FOG-2 -/- embryos, thereby illustrating that 
FOG-2 acts exclusively through GATA-4. We hypothesized that novel cardiac defects 
would possibly be seen in the GATA-4 knock-in animas in addition to those present in the 
FOG-2 knock-out, providing evidence that GATA-4 functions through yet a different FOG 
related cofactor within the developing heart. 
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Methods 
All methods were performed by the author unless specifically stated otherwise. 
Targeted mutagenesis of the murine GATA4 gene 
An 8.2-kb Eco RV-Sac I fragment of murine GATA4 genomic DNA containing the 
N finger of GATA-4 (courtesy of Jeff Molkentin) was subcloned into pBluescript II KS 
(+/-) phagemid (Stratagene). By site-directed mutagenesis, Val 217 was changed to glycine 
(the codon GGC was changed to GTC; GeneEditor, Promega). (Site directed mutagenesis 
was performed with the help of J. Crispino). An intronic Bgl II site was changed to a Not I 
site to facilitate introduction of a floxed neomycin expression cassette. HSV-tk was cloned 
into a Sal I Site 5 of the homology region. 
The targeting construct was linearized with Pvu I and electroporated into TL1 ES 
cells. (Technical instruction on the culturing protocol for ES cells was provided by Carole 
Browne). Electroporation was performed as follows: A 10 cm plate of ES cells was washed 
with 5 ml 0.05% trypsin/EDTA. 2.5 ml 0.25% trypsin/EDTA was added, and cells were 
incubated at 37° for 4’. An additional 2.5 ml of 0.25% trypsin/EDTA was added and 
suspension was pipetted to break up clumps. Cells were incubated at 37° C for an additional 
2’ and 5 ml complete medium (80% DMED, 15% FCS, 2% PEN/STREP, 1% nucleoside 
mix, 1% L-Glutamine, 1%NEAA, 10A-4 M 2ME, 10A3 u/ml LIF) was added. After 
pipetting, cell suspension was transferred to a 15 mL tube. Plates were washed with 5 mL 
medium and were added to the tube. Cell suspension was pelleted at 1000 rpm/874°C. 
Cells were washed 2 x with EleBS, 1000 rpm/874°C, and were resuspended at 1.3 x 10 A7/ 
ml in HeBS. 25 ul (25-50 ug) of linearized targeting construct DNA was added to 0.75 ml 
of suspension for each electroporation. Cells were vortexed gently and incubated on ice for 
10’. Cells were electroporated in 0.4 cm gap cuvette at 500 uF and 250V, and were then 
incubated on ice for 10’. Electroporated cells were plated in 1EF (irradiated embryonic 
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fibroblast feeder cells) per protocol, in which electorporated cells were resuspended into 6 
mLs of medium and divided into 6, lmL suspensions added dropwise to each IEF plate. 24 
hours following initial plating, G418 (280 mg/ml stock) was added for final concentration 
of 280 ug/ml. 4ul of gancyclovir (5 x 10A-3M stock) was added for a final concentration 
of 2 X 10A-6M. 
Cells were fed daily with fresh G418, gancyclovir, and medium for 8 days. On days 
7 and 8, clones were scored, picked, trypsinized, and transferred to IEF feeder plates using 
sterile technique. ES clones were allowed to grow until they reached 40-70% confluence, at 
which point they were frozen and expanded for growth of cells to be used for DNA 
extraction and analysis. 12-well gel-coated plates were filled with ES medium, and freezing 
vials were prepared each containing 150 ul freezing mixture (20% DMSO/80% FCS). 
Clones were trypsinized and dispersed into single cell suspension. Each well was rinsed 
with 0.5 ml 0.05% trypsin. lOOul 0.25% trypsin was added to each well, cells were 
incubated for 5’ at 37°, 150 ul FCS was added to each well. 150 ul of this cell suspension 
was transferred to corresponding freezing vial, while the remaining cell suspension was 
added to corresponding well of DNA plate. Vials were placed in foam racks at -80°C 
before transferring to liquid nitrogen. DNA was isolated and purified from ES clones when 
cells were close to confluency. Each well was washed with 3 ml PBS. 600 ul lysis solution 
(GENTRA SYSTEMS) was added to each well, and cells were resuspended and pipetted 
into 1.5ml eppendorf tubes. Cells were incubated for 1 hour at 37 °C. 3 ul Rnase A solution 
(GENTRA SYSTEMS) was added to each eppendorf tube. Tubes were inverted 25X and 
incubated 1 hr at 37°. Protein precipitation was performed by cooling on ice 5 minutes, 
followed by the addition of 200 ul protein precipitation solution to each tube. Tubes were 
vortexed vigorously for 20 seconds, and centrifuged 14,000 rpm for 10 minutes at 4°C. 
Supernatant was poured into a new tube containing 600 ul isopropanol and was mixed by 
inverting 50x. Tubes were centrifuged at 14,000 rpm/374°C. Supernatant was poured off, 
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and 600ul of 70% ethanol was added to each tube. Tubes were centrifuged again at 14,000 
rpm/374°C. Supernatant was poured off, and tubes were inverted and allowed to air dry. 
DNA hydration was performed using lOOul of DNA hydration solution (GENTRA) per 
pellet. DNA was heated 1 hour at 65°C and allowed to rehydrate overnight at RT, and was 
stored at 4°C. 
Each sample of DNA was analyzed via Southern blot analysis in order to determine 
the presence of correctly targeted clones. The Gata4 coding exon used as a probe used for 
Southern blot analysis is detailed in figure 1. This exon was prepared as a random-primed 
DNA probe using the Boehringer-Mannheim Random Primed DNA Labeling kit and was 
purified using Boehringer-Mannheim Quick Spin G-25 Sephadex columns. Southern blots 
were performed using standard technique. ES clones that were found to be correctly 
targeted (2 out of 100) were expanded for stock as follows. Positive clones were thawed to 
one well of an IEF plate and was fed with fresh medium after 24 hours. When wells were 
50-70% confluent, they were split to 6 new wells of a 24 well IEF plate for PI stock. When 
these wells were 50-70% confluent, 1 well was used for karyotyping, and 4 wells were 
frozen for stock. The GATA4 gene from two independently generated, targeted ES clones 
was amplified by PCR, sequenced, and found to be correctly mutated in one clone. Two 
clones were corectly integrated, however, only one clone had both neo and the point 
mutation. Sequencing was performed by sequencing facility at Children’s Hospital and with 
the help of J. Crispino. This clone was injected into C57BL/6 blastocysts to generate 
chimeras. (Injection was performed by Y. Fujiwara). 
Mating of mice and categorization of their offspring was done together in 
collaboration with A. Chapedelaine and J. Crispino. Genotyping was done thereafter by 
Southern blot analysis, as described in the legend of Figure 1C. (Both J. Crispino and M. 
Lodish contributed to genotyping) Tail and yolk sac DNA extraction was performed as 
follows: 500ul lysis buffer (lOOmM Tris HCL pH 8.0, 5mM EDTA, 0.2% SDS, 200mM 
NaCl) and 2.5 ul proteinase K solution (at 20 mg/ml) was added to eppendorf tubes 
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containing fresh cut or frozen tail samples. Tails were incubated overnight at 55° C. The 
following morning, tunes were vortexed and spun at 10 minutes, maximum speed. 
Supernatant was poured into new tube containing 500 ul isoporpanol and shaken well. 
Tubes were spun an additional 2 minutes, maximum speed, and supernatant was poured off. 
lmL 70% ETOH was added to each tube which was then briefly vortexed. Samples were 
spun down, washed with ETOH, air-dried, and resuspended in 50 ul of 0.1 M Tris-HCL pH 
8.0, 0.1 M EDTA. Samples were analyzed via Southern blot as per standard protocol. 
Histological analysis 
Mouse embryos were isolated from GATA4 heterozygous knock-in matings 
between E10.5 and 13.5. Embryos were fixed in Bouin’s, dehydrated into increasing 
concentrations of ethanol, transferred into xylene, and sectioned in paraffin at 6 fim and 
stained with hematoxylin and eosin. Sectioning was performed independently by both the 
author and J. Crispino. Our slides were shared with Silvio Litovsky, a cardiac pathologist at 
Brigham and Women’s hospital. 
Immunohistochemistry 
Murine tissue used for immunohistochemistry was fixed in 10% formalin overnight, 
processed, and paraffin embedded using standard histologic techniques. Tissue sections 4/x 
thick were dewaxed in xylene then re-hydrated by passage through graded alcohol 
solutions. Sections were immersed in 10 mmole/L citrate buffer (pH 6.0) in a 
thermoresistant container and heated in a microwave oven (800 W,General Electric) at 
199°F for 30 min. A rabbit polyclonal antibody to GATA-4 (sc-9053, Santa Cruz 
Biotechnology) was used at a 1:50 dilution and detected by the Rabbit DAKO Envision 
Plus System, Peroxidase DAB (Dako). Negative controls were performed by substituting 
the primary antibody with species-and isotype-matched, nonimmune immunoglobulins. 
Additional controls included omission of the primary antibody as well as substitution of the 
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primary antibody of interest with one of differing specificity. (Immunohistochemistry of 
embryo sections was performed by Beth Thurberg, Cardiac pathologist at Brigham and 
Women’s Hospital, while genotyping of embryos and embryo preparation for sectioning 
was performed by the author). 
Whole-mount staining of hearts with the aFlk-1 and a ICAM-2 antibodies 
(obtained from Pharmingen) was performed independently by the author as well as by J. 
Crispino as follows. Embryos were collected in PBS and hearts were dissected out. Hearts 
were fixed in methanol: DMSO (4:1) overnight at 4°C. Hearts were transferred into 
methanol:DMSO:30% H2O2 (4:1:1) for 4-5 hours at RT. Hearts were rehydrated through 
decreasing concentrations of methanol into PBS. Hearts were incubated in PBMST (3% 
instant skim milk powder, 0.1% Triton X-100 in PBS) for 1 hour at RT, followed by 
overnight incubation with primary antibody diluted in PBSMT (1:50). The following 
morning, hearts were washed in PBMST twice at 4°C and 3 times at RT for 1 hour each. 
Hearts were incubated overnight at 4°C with the secondary antibody in PBMST at 4°C 
overnight. HRP coupled goat anti-rat IgG was used at a 1/100 dilution. The following 
morning, 5 washes in PBMST for 1 hour each were completed. Hearts were incubated in 
developing solution (sigma) for 20 minutes at RT. H2O2 was then added to 0.03% final 
concentration. Hearts were rinsed in PBT (0.2% BSA, 0.1% Triton X-100 in PBS) and then 
PBS for 5 minutes x 2 at RT, and then were fixed in 2% paraformaldehyde/ 0.1% 
glutarldehyde/ PBS at 4°C overnight. 
In situ hybridization analysis 
Whole mount hybridization was performed using riboprobes labeled with 
digoxigenin-UTP. Animal hearts were isolated surgically from embryos through 
dissection in PBS. Hearts were then fixed in 4% paraformaldehyde at 4° C overnight with 
gentle rocking. Hearts were washed twice in PBT for 5 minutes at 4° C and were 
dehydrated into increasing concentrations of methanol at room temperature. Digoxigenin- 
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UTP labeled RNA probe was synthesized as follows: the following reagents were mixed at 
room temperature, lOpl sterile distilled water, 4jli1 5 x transcription buffer, lpl 0.2M DTT, 
2pl nucleotide mix, lpl linearized plasmid (Ipg/pl), lpl placental ribonuclease inhibitor, lpl 
RNA polymerase. The reagent mixture was incubated at 37° for 2 hrs. 2pls of Dnase I 
were added, along with lOOpls of TE, lOpls 4M LiCl, and 300pl ethanol. Mixture was 
incubated at -20°C for 30 minutes, spun in a microcentrifuge at 4°C for 10 minutes, washed 
with 70 ethanol and air dried. The pellet was then re-dissolved in TE at O.lpg/pl and stored 
at -20°C. 
Pretreatment and hybridization of hearts was carried out as follows: Samples were 
rehydrated through decreasing concentrations of methanol in PBT, then bleached in 6% 
hydrogen peroxide in PBT for 1 hour at RT. Samples were then washed with PBT three 
times for 5 minutes each, then treated with lOpg/mg proteinase K in PBT for 15 minutes at 
RT. Embryos were then washed with 2 mg/ml glycine in PBT, followed by PBT for 5 min 
at RT. Embryos were re-fixed with 0.2% glutaraldehyde/ 4% paraformaldehyde in PBT for 
20 minutes at RT, followed by additional washes in PBT. Embryos were incubated in 
prehybridization solution (50% formamide, 5X SSC pH 4.5, 50pg/ml yeast RNA, 1% SDS, 
50pl/ml heparin) for 1 hour at 70°C. Prehybridization solution containing lOp probe was 
added, mixed, removed, and sample was incubated overnight at 70°C in 1 ml of 
hybridization solution. Post-hybridization washes were performed and embryos were 
preblocked with 10% sheep serum in TBST at RT for 2.5 hours. Blocking seurm was 
removed, 200 pi antibody solution was added to the embryos, which were then rocked 
overnight at 4°C. The following morning, hearts were washed in TBST 3 times for 5 
minutes each, 5 times for 1 hour each, and finally overnight. The following morning, hearts 
were washed 3 times with freshly prepared NTMT for 10 minutes each at RT. Hearts were 
incubated with developing solution (Boeringer Manneheim) in the dark for 4 hours. When 
reaction had completed, embryos were washed 2X with NTMT for 10 min at RT, reaction 
was stopped with PBT pH 5.5 for 10 minutes RT, hearts were post-fixed in 4% 
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paraformaldehyde in PBT + 0.1% glutarldehyde, and washed in increasing concentrations 
of glycerol to stabilize hearts for photography. 
Antibody solution was prepared as follows: 0.5 ml TBST was added to 3mg 
embryo powder and allowed to incubate at 70°C for 30 minutes. Sample was vortexed for 
10 minutes, then cooled on ice. 5pl sheep serum and lp.1 of anti-dig AP (Boeringer 
Manneheim) were added. Sample was shaken gently at 4°C for 1 hour, then spun for 10 
minutes at 4°C, and finally the supernatant was diluted to 2 ml with 1% sheep serum in 
TBST. 
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Results 
We sought to establish an intrinsic role for GATA-4 in heart development by 
generating mice harboring a knock-in mutation that cripples its interaction with FOG-2 or 
other FOG-factors. Residue 217 of GATA-4, which corresponds to Val 205 of GATA-1, 
was changed to glycine by gene targeting in embryonic stem (ES) cells. This residue faces 
away from DNA (Fig.lA) and lies within the GATA -N finger:FOG interface. Substitution 
with glycine disrupts interaction with either FOG-1 or FOG-2 and leaves DNA-binding 
properties of GATA factors unperturbed. Targeted mutation of murine Gata4 was 
accomplished with the construct depicted in Figure IB. A floxed neomycin resistance 
cassette was incorporated into an intron downstream of the exon containing V217. ES cells 
harboring both the V217G mutation and the floxed neomycin cassette were injected into 
host blastocysts to generate chimeras. Gata4 +/ki mice appeared normal. No livebom 
homozygotes resulted from interbreeding of heterozygous offspring, indicating the Gata4 
ki/ki embryos are embryonic lethal. Southern blotting of timed matings (Fig. 1C) 
demonstrated that Gata4 ki/ki embryos die between El 1.5 and E13.5. Their gross 
appearance was remarkably similar to that of Fog2 -/- embryos (20, 21). Gata4 ki/ki 
embryos are pale and edematous, compared with wild-type littermates, and peripheral 
hemorrhage is often observed (Fig.2A,B).The neomycin cassette was removed in some 
strains by interbreeding with a Cre-recombinase-deleter strain (22).No differences in 
phenotype were observed between strains containing or lacking the neomycin cassette. 
Furthermore, heterozygotes were bom at the expected frequency and displayed no 
detectable phenotype, arguing that the GATA-4 mutant protein does not act in a dominant 
negative manner. 
Wild-type and the GATA-4 ki/ki embryonic hearts at El2.5 were examined in serial 
sections, cut in the transverse plane, and inspected from the cephalic to the caudal aspect of 
the specimens (Fig.2C -H).Gata4 ki/ki hearts revealed a double-outlet right ventricle where 
both great arteries arise from the right ventricle (Fig.2F).The ventricular septal defect is the 
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only outlet for the left ventricle (Fig.2F). In addition, the endocardial cushion cells of both 
the pulmonary and aortic outflow tracts appear more numerous than in wild-type embryos. 
Furthermore, robust mitotic activity is evident in these areas, and the pulmonary and aortic 
outflow tracts comingle in some planes of section. In wild-type embryos, however, the 
pulmonary and aortic outflow tracts display distinct endocardial cushions (Fig. 2E), Right 
and left atria of the mutant are massively dilated and freely communicate (Fig.2D,H),and a 
common atrioventricular valve opens into the center of a large ventricular cavity, which lacks 
a ventricular septum (Fig.2H). In contrast to a wild-type heart, in which two distinct 
atrioventricular valves (the tricuspid and mitral valves;Fig.2G) develop in continuity with the 
septum and with the aortic valve, respectively (Fig.2E), the common AV valve in the mutant 
heart has no fibrous continuity with the aortic valve. In addition, Gata4 ki/ki myocardium 
appears thin (cf.Fig. 2G,H).These abnormalities were consistently seen in the GATA-4 ki/ki 
embryos. Similarly, complete penetrance was also observed in FOG-2 -/- embryos (21). 
The morphology of Gata4 ki/ki hearts resembles that seen in Fog2 -/- embryos, 
however a few key differences exist. Both the Gata4 ki/ki and Fog2 -/- hearts exhibit 
enlarged atria, thin myocardium, ventricular septal defect, and a common AV valve. However, 
while the Fog2 -/- hearts have a severely obstructed pulmonary trunk, Gata4 ki/ki hearts 
were unique in terms of the presence of a double-outlet right ventricle. In addition, Gata4 
ki/ki hearts had increased cellularity in the semilunar valves and outflow tracts that was not 
observed in the Fog2 -/- hearts. 
To validate that the observed phenotype results from expression of a qualitatively 
different GATA-4 protein rather than from an altered pattern, or level, of expression, we 
examined GATA-4 protein expression. Wild-type and Gata4 ki/ki E12.5 hearts were 
sectioned in the sagittal plane and immunostained for expression of GATA-4 (Fig.3A,B).At 
this stage, GATA-4 protein is present in both endocardium and myocardium of developing 
atria and ventricles. Immunostaining is strongest in surface endothelial cells and 
mesenchymal cells of the endocardial cushion tissues, which develop into the semilunar 
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(Figs.3B,F)and atrioventricular valves (Fig. 3D,H). GATA-4 protein is also present in the 
embryonic liver and gut epithelium in both wild-type and mutant embryos, as expected 
(Fig.3A,E; 23). Taken together, these studies demonstrate that GATA-4 ki protein is 
expressed comparably to wild-type protein. 
In several respects, the morphology of Gata4 ki/ki hearts resembles that seen of 
Fog2 -/- embryos. A distinctive feature of Fog2 -/- hearts is the absence of coronary 
vasculature (21).To examine the status of their coronary vasculature, Gata4 ki/ki hearts were 
immunostained for two endothelial cell markers. Flk-1, the receptor for vascular endothelial 
growth factor (VEGF), is essential for vascular development throughout the mouse (24). 
Flk-1 is not detectable in Gata4 ki/ki hearts, though lung tissue stains intensely (Fig.4A). 
Similarly, abundance of the intracellular adhesion molecule-2 (ICAM-2) is reduced in 
Gata4 ki/ki hearts; note the absence of the developing capillary plexus (Fig.4B, arrows). 
These findings are indistinguishable from those reported previously for Fog2 -/- hearts, 
which exhibited an identical early block in the formation of coronary vessels (21). As such, 
they provide strong evidence that FOG-2 serves as a transcriptional cofactor for GATA-4 in 
myocardium as an essential step in the initiation of coronary vascular development. 
Normal vessel development occurs as epicardial cells undergo an epithelial-to- 
mesenchymal transition, giving rise to the subepicardial coronary vasculature (25). Studies 
of Fog2 -/- embryos showed that despite formation of an intact epicardial layer and 
expression of epicardium-specific genes in Fog2 -/- hearts, markers of cardiac vessel 
develpoment (ICAM-2 and FLK-1) were not detected. Our current hypothesis is that the 
interaction between GATA-4 and FOG proteins is essential for the development of coronary 
vasculature from epicardium. We postulate that this specific protein-protein interaction is 
nescessary for the critical step of epithelial to mesenchymal transformation, as represented 
by the failure to activate FLK-1 and ICAM-2 expression (Figure 5). 
Of numerous myocardial-expressed genes assayed in Fog2 -/- hearts, only the basic 
-helix -loop helix eHand and dHand genes were altered in their expression on loss of Fog2 
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(21). To assess this phenotype in Gatci4 ki/ki hearts, the expression of Hand genes was 
examined by RNA in situ hybridization. Expression of eHand is reduced in the 
myocardium of Gatci4 ki/ki hearts relative to that seen in wild-type hearts (Fig.4C). 
Interestingly, whereas the expression of eHand in the outer curvature of the ventricles is 
reduced (Fig.4C, white arrows), its expression in the outflow tract is increased (Fig.4C, dark 
arrows).This increased staining likely results from the increased cellularity within this 
region of the Gata-4 mutant hearts and was not observed in Fog2 - deficient hearts 
(Fig.2F).In contrast, the expression of dHand is only marginally reduced in the mutant heart 
(Fig 4D). 
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Figure 1. Targeting the GATA4-FOG-2 interaction in mice.(A )Structure of the N finger 
of chicken GATA-1 modeled with DNA. The essential valine is highlighted in red in both 
the illustration and in the sequence alignment of the murine factors, GATA-1 (V205) and 
GATA-4(V217),shown below. Note the high conservation of the residues within the N 
finger of the two GATA proteins.(B ) Partial restriction map of the murine Gata4 wild-type 
locus (top), the Gata4 knock-in targeting vector (middle),and targeted homologous 
recombination before excision of the selection cassette (bottom).The targeting construct 
contains the HSV-tk and neomycin resistance (neo R ) genes under the control of the 
mouse phosphoglycerate kinase (PGK) promoter. Homologous recombination results in 
replacement of wild-type Gata4 with genomic DNA harboring a substitution of valine to 
glycine at position 217 in the N finger of GATA-4, as well as the incorporation of neomycin 
cassette. Gata4 coding exons are shown as empty boxes, whereas the exon used as a probe 
used for Southern blot analysis is highlighted by a black box. S, Sac I;E,Eco RV;B,Bgl 
II;N,Not I.(C ) Southern blot analysis of ES cell DNA and mouse tail DNA (left 
panel)showing the presence of heterozygous mutant animals (ki/+). Analysis of E12.5 
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embryos resulting from an intercross of Gata4 knock-in heterozygotes (ki/+), 
demonstrating the presence of all expected genotypes (right panel).The wild-type allele 
(WT) generated a 3.8-kb band after digestion of genomic DNA with Bgl II. In contrast, the 
knock-in mutated allele (Ki) generated a much larger fragment because of the replacement 
of the intronic Bgl II site with Not I. 
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Figure 2. Heart defects in Gata4 mutant (ki/ki)embryos. (A ,B ) 3 homozygote, complete 
mutant embryos from separare litters were compared with 3 corresponding wild-type 
littermates. Wild-type (A )and mutant (B) embryos at E13.5 showing edema and peripheral 
hemorrhaging in a mutant.(C ,D )Transverse sections through wild-type (C )and mutant (D) 
hearts at El 3.5 at the level of the atrioventricular (AV) junction show enlarged atria, thin 
myocardium, and the absence of a ventricular septum. Original magnification, 40 x.(E ,F) 
Transverse sections of wild-type (E) and mutant (F )hearts at the level of the aortic and 
pulmonary outflow tracts. Gata4 ki/ki hearts have a double outlet right ventricle, in which all 
blood exits the heart into both great arteries, the pulmonary artery and the aorta. The left 
ventricle, which normally delivers blood to the aorta, fails to communicate with an artery in 
the mutant. Also note the apparent increase in cel I ularity of both outflow tracts and 
semilunar valves in the mutant. Original magnification, 400 x.(G ,H ) Transverse sections of 
wild-type (G )and mutant (H jhearts at the level of the AV junction. Gatci4 ki/ki hearts form 
a common AV valve that is situated between the left and right ventricles. For comparison, the 
mitral (MV) and tricuspid (TV) valves of the wild-type heart are indicated by arrowheads. 
Original magnification, lOOx. 
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Figure 3. Expression of Gcitci4 in the heart. Sagittal sections of wild-type (A -D )and 
Gata4 ki/ki (E-H )embryos at E12.5 were stained with an ocGATA-4 antibody. Both wild- 
type and mutant hearts display similar staining within the semilunar and AV valve cells. 
Note the staining of outflow tracts in both the wild-type and the mutant heart. At, atrium; 
AV,atrioventricular;V,ventricle. Original magnification,A,E,G,40x;B,D,F,H,400x;C, lOOx. 
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Figure 4. Aberrant expression of coronary vessel and myocardial transcripts.(A ) Staining 
of E12.5 wild-type (+/+) and mutant (ki/ki) hearts with an ocFIk-1 antibody (dorsal view). 
N = 2. Staining of the mutant is vastly reduced within the heart, but lung tissue stained with 
equal intensity.(B )Immunostaining of wild-type and mutant hearts at E12.5 using the 
aICAM-2 antibody (dorsal view). N -2. Note the absence of a well-developed vascular tree 
in the mutant heart.(C )Whole-mount RNA in situ staining of eHand in El 1.5 hearts. N=3. 
eHand expression is down-regulated in the outer myocardial layer (white arrows),whereas 
there is more intense staining in the outflow tract of the mutant (dark arrows).Note that the 
direction of the outflow tract relative to the heart is altered in the mutant, consistent with the 
pathological findings. (D) Whole-mount RNA in situ staining of dHAND in E 11.5 hearts. 
N-3. The expression of dHand (blue) is only marginally reduced in the mutant heart. 
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Figure 5. Model of arrest in development of coronary vasculature caused by disruption of 
GATA-4 and FOG-2 proteins. FOG-2 serves as a transcriptional cofactor for GATA-4 in 
myocardium at an essential step in the initiation of coronary vascular development, the 
initiation of epithelial to mesenchymal transformation of epicardial cells. (Modeled after 
Figure 7, reference 21). 
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Discussion 
Our data point to essential roles for the GATA-4:FOG-2 interaction in heart 
moiphogenesis and coronary vascular development. The power of our analysis rests on the 
exquisite specificity of the knock-in mutation within the N finger of GATA-4. The residue 
we have chosen to modify is required for physical interaction with FOG-like proteins and 
does not influence the DNA-binding specificity of the GATA-protein (6). Although 
displaying many similar features, Gata4 ki/ki hearts are distinguished from Fog2 -/- hearts, 
however, by the presence of a double-outlet right ventricle and defects in the semilunar 
valves and outflow tracts. As immunostaining confirmed that GATA-4 is expressed at wild- 
type levels in the semilunar valves of the Gata4 mutant heart, it is likely that another FOG, 
or FOG-like protein, that functions as a cofactor for GATA-4 in transcription is expressed 
in these valve cells. Though high-level expression of the only other known vertebrate FOG- 
like factor, FOG-1, has not previously been observed by in situ RNA hybridization, FOG-1 
transcripts are present at low levels in Northern blots of total heart RNA (A.P.Tsang and 
S.H.Orkin, unpubl.). Thus, it is quite possible that disruption of the physical interaction 
between GATA-4 and FOG-1, or a novel, undefined FOG protein, is responsible for 
impaired development of the semilunar valves and the appearance of a double-outlet right 
ventricle. 
Given the profound effects of mutation of either GATA-4 or FOG-2 proteins on 
heart morphogenesis in mice, it is worth considering their potential relevance to human 
congenital heart defects, such as the Tetralogy of Fallot or the double-outlet right ventricle 
(26). It is therefore logical to evaluate FOG and GATA factors as candidate genes for 
congenital cardiac defects in humans. Indeed, haploinsufficiency at the GATA-4 locus is 
often seen in patients with del(8)(p23.1) and congenital heart disease, and it has been 
postulated that this GATA-4 deficiency may contribute to the phenotype of patients with 
monosomy of 8p23.1 (27). Further elucidation of the complex pathways of transcription 
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factors modelling cardiogenesis will ultimately help us to better understand cardiac 
development and congenital heart disease. 
Whereas mutation of several genes, such as Jmj (Jumanji), Sox4 ,and Egfr/Shp2, 
give rise to the double-outlet right ventricle defect in mice (28, 29, 30), and defects in other 
genes for transcription factors, such as FOG2, NF1, neurotrophin 3, and RXR °<= result in 
all or a subset of the Tetralogy of Fallot (31, 32, 33, 34, 21), the consistent and combined 
phenotype seen in the Gata4 ki/ki mice is unique. Although it is sometimes difficult to 
distinguish between double-outlet right ventricle with associated pulmonary stenosis and the 
Tetralogy of Fallot, it is clear that the defects in the GATA-4 ki/ki hearts are different in the 
outflow tracts than those observed in Fog2 -deficient embryos. 
Through the use of an altered specificity mutant, we demonstrate that GATA-4 very 
likely requires both FOG-2 and an additional FOG, or FOG-like protein, as cofactors for 
distinct aspects of heart development. Interaction with FOG-2 is essential for the initiation 
of coronary vasculature and for some morphogenetic events, whereas interaction with a 
distinct FOG protein appears to be required for formation of cardiac valves. Our results are 
surprising in that two other GATA-factors, GATA-5 and GATA-6, are also expressed in 
myocardium, and indirect data have suggested that they might compensate for the absence 
of GATA-4. For example, previous studies show that GATA-4 is dispensable for terminal 
differentiation of cardiomyocytes and that Gata4 -/-ES cells contribute to all layers of the 
heart. In these experiments, it has been suggested that GATA-5 or GATA-6 functionally 
replace GATA-4 (35). It is possible that proper expression of the GATA-4 ki/ki protein, as 
distinguished from the absence of GATA-4 in the knock-out situation, precludes 
compensation by other GATA factors. Indeed, immunostaining with an °c GATA-6 
antibody demonstrated that GATA-6 expression, though similar to that of GATA-4, is not 
up-regulated in the Gata4 ki/ki hearts (data not shown). In addition, staining with °=GATA- 
5 antibody revealed a normal pattern in Gata4 ki/ki hearts (data not shown). As GATA-5 is 
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no longer expressed within the ventricles of the heart at E12.5, it is unlikely that it would 
compensate for the absence of functional GATA-4 (8). 
Our findings implicate GATA-4 as the principal GATA factor relevant to heart 
morphogenesis and coronary vasculature development and as the primary partner for FOG 
proteins in the heart. This represents the second example of transcriptional regulation 
involving GATA -FOG protein complexes and argues for their broad involvement as key 
regulators of multiple developmental pathways. 
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